Health-related quality of life among children with hereditary angioedema

Batya Engel-Yeger1, Henriette Farkas2, Shmuel Kivity3

  • 1Department Faculty of Social Welfare and Health Sciences, University of Haifa Occupational Therapy, Haifa, Israel.

Insights

Children with symptomatic hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE) experience significantly lower quality of life. Health-related quality of life is negatively impacted by attack frequency and location, particularly affecting school and physical well-being.

Area of Science:

  • Pediatrics
  • Immunology
  • Genetics

Background:

  • Hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE) significantly impacts patients' quality of life.
  • Assessing health-related quality of life (HRQoL) in pediatric C1-INH-HAE patients is crucial for understanding disease burden.

Purpose of the Study:

  • To evaluate the health-related quality of life (HRQoL) in children diagnosed with C1-INH-HAE.
  • To compare HRQoL between pediatric C1-INH-HAE patients and healthy controls.

Main Methods:

  • A cross-sectional study involving 34 children with C1-INH-HAE and 64 healthy controls aged 3-18 years.
  • HRQoL was assessed using the Pediatric Quality of Life Inventory (PedsQL™) 4.0 Generic Core Scales.
  • Disease activity and attack sites were recorded to correlate with HRQoL outcomes.

Main Results:

  • Children with C1-INH-HAE attacks reported lower overall HRQoL, including school and psychosocial dimensions, compared to controls.
  • A higher frequency of C1-INH-HAE attacks correlated negatively with total, school-related, and psychosocial HRQoL scores.
  • Multisite attacks (laryngeal, abdominal, peripheral) resulted in significantly lower HRQoL across total, physical, and school domains compared to solely peripheral attacks.

Conclusions:

  • Symptomatic pediatric C1-INH-HAE is associated with impaired health-related quality of life.
  • The frequency and location of C1-INH-HAE attacks are key determinants of reduced HRQoL in children.
  • School and physical domains are most affected by C1-INH-HAE attacks, highlighting the need for targeted interventions.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
588
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.5K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
1000
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
575
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
434
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
398